Related Experiment Video
Updated: Apr 13, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
New insights into the mechanisms of diastolic dysfunction in patients with type 2 diabetes
Al Bayraktar1, Uğur Canpolat, Edis Demiri
1Cardiology Clinic, Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital , Trabzon , Turkey.
Background:
Little is known about the role of advanced glycation end products (AGEs) and their receptor (RAGE) in diabetic cardiovascular complications. Therefore, we aimed to evaluate the association of serum soluble RAGE (sRAGE) levels and left ventricular (LV) diastolic dysfunction in patients with type 2 diabetes.
Methods:
Our study consisted of 40 patients with type 2 diabetes and 40 age- and sex-matched healthy control group. Subjects with age ≥ 50 years old and any cardiovascular risk factors or conditions were excluded from the study. Serum sRAGE levels determined by enzyme-linked immunosorbent assay and LV diastolic dysfunction were evaluated according to current American Society of Echocardiography guidelines.
Results:
Baseline characteristics were similar between groups except body mass index, waist-hip ratio, and fasting glucose levels. Serum sRAGE level was significantly lower in diabetic group compared with control group (676 ± 128 vs. 1044 ± 344, p < 0.05). Diastolic dysfunction was observed in 50% of diabetic patients (40% grade I and 10% grade II). Correlation analysis showed that serum sRAGE was negatively correlated with duration of diabetes, septal E'/A', lateral E'/A', and average E/E'. In multivariate regression analysis, serum sRAGE level was strongly associated with diastolic dysfunction in patients with type 2 diabetes.
Conclusion:
Our study showed that serum sRAGE level was significantly lower in type 2 diabetic patients aged < 50 years old. Also, sRAGE has negative correlation with the duration of diabetes and it was significantly associated with the presence of diastolic dysfunction in type 2 diabetes.
Insights
Serum soluble RAGE (sRAGE) levels are lower in type 2 diabetes patients and linked to diastolic dysfunction. Lower sRAGE indicates higher risk for diabetic cardiovascular complications.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- The role of advanced glycation end products (AGEs) and their receptor (RAGE) in diabetic cardiovascular complications remains largely unknown.
- Investigating the association between serum soluble RAGE (sRAGE) and left ventricular (LV) diastolic dysfunction in type 2 diabetes is crucial.
Purpose of the Study:
- To evaluate the association between serum sRAGE levels and left ventricular diastolic dysfunction in patients with type 2 diabetes.
- To explore the correlation of sRAGE with diabetes duration and diastolic dysfunction parameters.
Main Methods:
- A study involving 40 type 2 diabetes patients and 40 age/sex-matched healthy controls.
- Exclusion criteria included age ≥ 50 years and existing cardiovascular risk factors.
- Serum sRAGE levels were measured using enzyme-linked immunosorbent assay; LV diastolic dysfunction was assessed per American Society of Echocardiography guidelines.
Main Results:
- Serum sRAGE levels were significantly lower in the diabetic group compared to controls (676 ± 128 vs. 1044 ± 344, p < 0.05).
- Diastolic dysfunction was present in 50% of diabetic patients (40% grade I, 10% grade II).
- Serum sRAGE negatively correlated with diabetes duration and LV diastolic function parameters (septal E'/A', lateral E'/A', average E/E'); it was strongly associated with diastolic dysfunction in multivariate analysis.
Conclusions:
- Serum sRAGE levels are significantly lower in type 2 diabetic patients under 50 years old.
- sRAGE shows a negative correlation with diabetes duration.
- Reduced serum sRAGE is significantly associated with the presence of diastolic dysfunction in type 2 diabetes.
More Related Videos
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications